High expression of heat shock protein 105 predicts a favorable prognosis for patients with urinary bladder cancer treated with radical cystectomy

Kawai,Taketo; Enomoto,Yutaka; Morikawa,Teppei; Matsushita,Hirokazu; Kume,Haruki; Fukayama,Masashi; Yamaguchi,Hirotsugu; Kakimi,Kazuhiro; Homma,Yukio

doi:10.3892/mco.2013.203

January-February 2014 Volume 2 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-February 2014 Volume 2 Issue 1

Full Size Image

Article

High expression of heat shock protein 105 predicts a favorable prognosis for patients with urinary bladder cancer treated with radical cystectomy

Authors:
- Taketo Kawai
- Yutaka Enomoto
- Teppei Morikawa
- Hirokazu Matsushita
- Haruki Kume
- Masashi Fukayama
- Hirotsugu Yamaguchi
- Kazuhiro Kakimi
- Yukio Homma
View Affiliations / Copyright

Affiliations: Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo 1138655, Japan, Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo 1138655, Japan, Department of Immunotherapeutics, Graduate School of Medicine, The University of Tokyo, Tokyo 1138655, Japan, Technical Affairs Division, Kyodo Byori Inc., Kobe, Hyogo 6512112, Japan
Pages: 38-42
|
Published online on: October 18, 2013

https://doi.org/10.3892/mco.2013.203
Expand metrics +

Abstract

Heat shock protein 105 (Hsp105) is one of the cancer/testis antigens, which is overexpressed in a variety of cancer cells, including urinary bladder cancer, and has been investigated as a target molecule for immunotherapy due to its immunogenicity. In this study, we assessed the expression of Hsp105 in primary bladder cancer samples from 84 patients treated with radical cystectomy, using immunohistochemical analysis, and investigated its correlation with clinicopathological characteristics and cancer‑specific survival. The immunoreactivity of Hsp105 expression was evaluated as a score of 0‑3, according to the intensity of the signal. The Hsp105 expression was high (score 2 or 3) in 31 cases and low (score 0 or 1) in 53 cases; however, it was not significantly correlated with age, nuclear grade, pathological tumor stage and previous intravesical Bacillus Calmette‑Guérin immunotherapy. Female gender, lymphovascular invasion and lymph node metastasis were associated with low Hsp105 scores, although the differences were not statistically significant (P=0.071, 0.061 and 0.175, respectively). However, a high Hsp105 score was significantly associated with a favorable prognosis (P=0.017) and was identified as an independent prognostic factor by multivariate analysis (P=0.032; hazard ratio, 2.34). These findings suggested that the expression of Hsp105 may be a novel indicator of a favorable prognosis in bladder cancer.

View Figures

View References

1.	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2.	Hautmann RE, Gschwend JE, de Petriconi RC, Kron M and Volkmer BG: Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol. 176:486–492. 2006. View Article : Google Scholar : PubMed/NCBI
3.	Shariat SF, Karakiewicz PI, Palapattu GS, et al: Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol. 176:2414–2422. 2006. View Article : Google Scholar : PubMed/NCBI
4.	Lindquist S and Craig EA: The heat-shock proteins. Annu Rev Genet. 22:631–677. 1988. View Article : Google Scholar
5.	Takayama S, Reed JC and Homma S: Heat-shock proteins as regulators of apoptosis. Oncogene. 22:9041–9047. 2003. View Article : Google Scholar : PubMed/NCBI
6.	Sreedhar AS and Csermely P: Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review. Pharmacol Ther. 101:227–257. 2004. View Article : Google Scholar : PubMed/NCBI
7.	Suto R and Srivastava PK: A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1585–1588. 1995. View Article : Google Scholar : PubMed/NCBI
8.	Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M and Vile RG: Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med. 4:581–587. 1998. View Article : Google Scholar : PubMed/NCBI
9.	Nakatsura T, Senju S, Yamada K, Jotsuka T, Ogawa M and Nishimura Y: Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. Biochem Biophys Res Commun. 281:936–944. 2001. View Article : Google Scholar : PubMed/NCBI
10.	Yamagishi N, Saito Y, Ishihara K and Hatayama T: Enhancement of oxidative stress-induced apoptosis by Hsp105alpha in mouse embryonal F9 cells. Eur J Biochem. 269:4143–4151. 2002. View Article : Google Scholar : PubMed/NCBI
11.	Hatayama T, Yamagishi N, Minobe E and Sakai K: Role of hsp105 in protection against stress-induced apoptosis in neuronal PC12 cells. Biochem Biophys Res Commun. 288:528–534. 2001. View Article : Google Scholar : PubMed/NCBI
12.	Hosaka S, Nakatsura T, Tsukamoto H, Hatayama T, Baba H and Nishimura Y: Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo. Cancer Sci. 97:623–632. 2006. View Article : Google Scholar : PubMed/NCBI
13.	Yamagishi N, Ishihara K, Saito Y and Hatayama T: Hsp105 family proteins suppress staurosporine-induced apoptosis by inhibiting the translocation of Bax to mitochondria in HeLa cells. Exp Cell Res. 312:3215–3223. 2006. View Article : Google Scholar : PubMed/NCBI
14.	Kai M, Nakatsura T, Egami H, Senju S, Nishimura Y and Ogawa M: Heat shock protein 105 is overexpressed in a variety of human tumors. Oncol Rep. 10:1777–1782. 2003.PubMed/NCBI
15.	Mohtasham N, Babakoohi S, Montaser-Kouhsari L, et al: The expression of heat shock proteins 27 and 105 in squamous cell carcinoma of the tongue and relationship with clinicopathological index. Med Oral Patol Oral Cir Bucal. 16:e730–e735. 2011. View Article : Google Scholar : PubMed/NCBI
16.	Oda T, Morii E, Inoue M, Ikeda J, Aozasa K and Okumura M: Prognostic significance of heat shock protein 105 in lung adenocarcinoma. Mol Med Rep. 2:603–607. 2009.PubMed/NCBI
17.	Zappasodi R, Bongarzone I, Ghedini GC, et al: Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target. Blood. 118:4421–4430. 2011. View Article : Google Scholar : PubMed/NCBI
18.	Lebret T, Watson RW, Molinie V, et al: Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer. 98:970–977. 2003. View Article : Google Scholar : PubMed/NCBI
19.	Kamada M, So A, Muramaki M, Rocchi P, Beraldi E and Gleave M: Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells. Mol Cancer Ther. 6:299–308. 2007. View Article : Google Scholar
20.	Urushibara M, Kageyama Y, Akashi T, et al: HSP60 may predict good pathological response to neoadjuvant chemoradiotherapy in bladder cancer. Jpn J Clin Oncol. 37:56–61. 2007. View Article : Google Scholar
21.	Syrigos KN, Harrington KJ, Karayiannakis AJ, et al: Clinical significance of heat shock protein-70 expression in bladder cancer. Urology. 61:677–680. 2003. View Article : Google Scholar : PubMed/NCBI
22.	Fajkovic H, Halpern JA, Cha EK, et al: Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. 29:457–463. 2011. View Article : Google Scholar : PubMed/NCBI
23.	May M, Stief C, Brookman-May S, et al: Gender-dependent cancer-specific survival following radical cystectomy. World J Urol. 30:707–713. 2012. View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

High expression of heat shock protein 105 predicts a favorable prognosis for patients with urinary bladder cancer treated with radical cystectomy

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles